Behavior of Type 2 Diabetes Mellitus in Morbid Obese Patients Submitted to Gastric Bypass

Abstract

Gastric bypass is effective in controlling DM2 in morbid obese patients.

Laparoscopic Duodenal–Jejunal Exclusion in the Treatment of Type 2 Diabetes Mellitus in Patients with BMI < 30 kg/m2 (LBMI)

“…The large variability in clinical treatment results and the growing economic impact of the DM treatment and its complications worldwide justify the search for new and efficient treatment methods, whether clinical or surgical. In the past two decades, with the advancement of bariatric surgery and the observation of a successful glycemia control in patients who underwent Roux-en-Y gastric bypass and biliopancreatic diversion (Scopinaro & Duodenal Switch), many groups have been trying to elucidate the mechanisms associated with glycemia control [4][5][6][7][8]. At first, it was thought that glycemia stabilization would be a direct consequence of weight loss induced by surgery.…”

O efeito em curto prazo do bypass gástrico sobre pacientes obesos diabéticos

“…Schauer et al, in a four-year postoperative follow-up, observed that blood glucose returned to normal in 83% of cases and improved in 17% 12 . Other authors found significant reductions in blood glucose levels compatible with partial remission of T2DM in an average of 12 to 24 months post-operatively 4,17 . The adjustable gastric band procedures are associated with a lower average (50-60%) of clinical remission of T2DM 18 .…”

“…Type-2 Diabetes is a disorder associated with obesity in approximately 20% of patients 4 . In this study, 9.4% of obese patients undergoing gastric bypass had diabetes, approximately half of that in the literature.…”

“…The prevalence of obesity and T2DM increased exponentially, constituting one of the largest problems of public health 3 . Beyond weight loss, surgical treatment of morbid obesity causes control of comorbidities and mainly T2DM 4 .…”

Bariatric Surgery for Obesity: Surgical Approach and Variation in In-Hospital Complications in New York State

“…A number of studies have reported dramatic benefits for obese patients treated with bariatric surgery as compared to those treated with non-surgical therapies. Among these reported benefits are reductions in long-term mortality [3][4][5][6], decreased risk of cancer associated with severe obesity [7,8], and improved rates of recovery from diabetes [9], hypertension, and related cardiovascular diseases [10]. Other studies have also illustrated greater and sustained long-term weight loss for those undergoing bariatric surgery compared to those treated non-surgically [11][12][13].…”